These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8658903)

  • 1. Effect of recipient T cell subset depletion on graft coronary arteriosclerosis induction in the rat retransplant model.
    Izutani H; Miyagawa S; Shirakura R; Mikata S; Tanemura M; Fukushima N; Nakata S; Matsuda H
    Transplant Proc; 1996 Jun; 28(3):1828-9. PubMed ID: 8658903
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft coronary arteriosclerosis in rat heart transplant model with FK 506 short-term administration.
    Izutani H; Miyagawa S; Matsumiya G; Nakata S; Shimazaki Y; Matsuda H; Shirakura R
    Transplant Proc; 1995 Feb; 27(1):579-81. PubMed ID: 7533425
    [No Abstract]   [Full Text] [Related]  

  • 3. Essential initial immunostimulation in graft coronary arteriosclerosis induction detected by retransplantation technique in rats: the participation of T cell subsets.
    Izutani H; Miyagawa S; Mikata S; Shirakura R; Matsuda H
    Transpl Immunol; 1997 Mar; 5(1):11-5. PubMed ID: 9106329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No coronary atherosclerotic changes were found after heart transplantation in tolerance-induced rats.
    Ito H; Hamano K; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K
    Transplant Proc; 1996 Jun; 28(3):1823. PubMed ID: 8658900
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of natural killer cells and macrophages on the course of acute graft rejection following allogeneic heart transplantation in the rat.
    Dresske B; Zhu X; Peters J; Brötzmann K; Fändrich F
    Transplant Proc; 1996 Dec; 28(6):3259-60. PubMed ID: 8962264
    [No Abstract]   [Full Text] [Related]  

  • 6. The presence of donor-reactive CD4 T cells in early-phase liver-induced tolerance in rats: analysis using donor passenger leukocytes from the recipient.
    Hashimoto T; Yamaguchi J; Gu W; Kanematsu T
    Transpl Immunol; 2006 Jan; 15(3):205-9. PubMed ID: 16431287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat kidney graft survival after elimination of MHC class II-positive cells by perfusion with monoclonal antibody.
    Oko A; Krzymański M; Deja A; Pawliczak E; Idasiak-Piechocka I
    Transplant Proc; 1996 Dec; 28(6):3480-2. PubMed ID: 8962353
    [No Abstract]   [Full Text] [Related]  

  • 8. Does endotoxin accelerate rejection in a cardiac allograft model?
    Pirenne J; Médot M; Battafarano R; Benedetti E; Kim S; Dunn DL
    Transplant Proc; 1996 Oct; 28(5):2463-4. PubMed ID: 8907903
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of transplantation tolerance using a nondepleting anti-CD4 MAb and donor-specific transfusion before transplantation: evidence that a critical period of time is required for the development of immunological unresponsiveness.
    Saitovitch D; Bushell AR; Morris PJ; Wood KJ
    Transplant Proc; 1995 Feb; 27(1):117-8. PubMed ID: 7878834
    [No Abstract]   [Full Text] [Related]  

  • 10. The importance of targeting the CD4+ T cell subset at the time of antigenic challenge for induction of prolonged vascularized allograft survival.
    Sablinski T; Sayegh MH; Kut JP; Tilney NL; Milford EL; Kupiec-Weglinski JW
    Transplantation; 1992 Jan; 53(1):219-21. PubMed ID: 1346346
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of ICAM-1 in chronic rejection in the rat heart transplantation model.
    Hamano K; Ito H; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K
    Transplant Proc; 1996 Jun; 28(3):1822. PubMed ID: 8658899
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of monoclonal antibody on corneal graft survival across major and minor histocompatibility mismatches.
    Duguid IG; Koulmanda M; Mandel TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):844. PubMed ID: 8438499
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant dimeric MHC antigens protect cardiac allografts from rejection and visualize alloreactive T cells.
    Fried A; Berg M; Sharma B; Bonde S; Zavazava N
    J Leukoc Biol; 2005 Sep; 78(3):595-604. PubMed ID: 16000395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microchimerism and graft acceptance: cardiac allografting with multiple minor histocompatibility antigen differences.
    Hara MH; Shibata K; Matsuzaki Y; Onitsuka T; Koga Y; Suzuki H; Yamashita A; Miyamoto M; Li XK; Suzuki S; Amemiya H; Yokoi Y; Yamaguchi A; Iwaya M; Masaki Y; Kimura H
    Transplant Proc; 1996 Jun; 28(3):1293-4. PubMed ID: 8658665
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of CD4 depleting and nondepleting monoclonal antibodies in the mouse heart allograft model.
    Han WR; Mottram PL; McKenzie IF
    Transplant Proc; 1993 Oct; 25(5):2933-4. PubMed ID: 8105591
    [No Abstract]   [Full Text] [Related]  

  • 16. Microchimerism and graft acceptance: cardiac allograft acceptance following antiadhesion molecules antibody therapy.
    Hara MH; Tanigawa M; Matsuzaki M; Onitsuka T; Shibata K; Koga Y; Suzuki H; Yamashita A; Miyamoto M; Li XK; Suzuki S; Amemiya H; Yokoi Y; Iwaya M; Yamaguchi A; Masaki Y; Miyasaka M; Kimura H
    Transplant Proc; 1996 Jun; 28(3):1370-1. PubMed ID: 8658699
    [No Abstract]   [Full Text] [Related]  

  • 17. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T-cell-dependent destruction of MHC class I disparate cardiac allografts.
    Morton AL; Bolton EM; Lawes CM; Porteous C; Bradley JA
    Transplant Proc; 1993 Feb; 25(1 Pt 1):102-3. PubMed ID: 8438240
    [No Abstract]   [Full Text] [Related]  

  • 19. Positive effects of anti-T-cell monoclonal antibodies on rat allograft survival.
    Claesson K; Larsson P; Holmdahl R; Klareskog L; Forsum U; Tufveson G
    Transplant Proc; 1987 Feb; 19(1 Pt 1):615-6. PubMed ID: 3079163
    [No Abstract]   [Full Text] [Related]  

  • 20. Partial T-cell depletion with monoclonal antibody improves the enhancing effect of donor-specific transfusion plus cyclosporine.
    Brunson ME; Tchervenkov JI; Alexander JW; Cofer BR
    Transplant Proc; 1991 Feb; 23(1 Pt 1):307-8. PubMed ID: 1990538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.